Is TRAP-6 suitable as a positive control for platelet reactivity when assessing response to clopidogrel

Platelets

Volumn 21, Issue 7, 2010, Pages 515-521

  Gremmel, Thomas ^a   Calatzis, Andreas ^b   Steiner, Sabine ^a   Kaider, Alexandra ^a   Seidinger, Daniela ^a   Koppensteiner, Renate ^a   Kopp, Christoph W ^a   Panzer, Simon ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Clopidogrel; platelet function tests; positive control; residual platelet reactivity; TRAP 6

Indexed keywords

ADENOSINE DIPHOSPHATE; CLOPIDOGREL; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING PARAMETERS; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; LIGHT TRANSMISSION AGGREGOMETRY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ELECTRODE AGGREGOMETRY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHEAR FLOW; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; AGED; BLOOD PLATELETS; CELL ADHESION MOLECULES; FEMALE; HUMANS; MALE; MICROFILAMENT PROTEINS; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; TICLOPIDINE;

EID: 77958018456     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2010.493587     Document Type: Article

References (24)

1. Jack DB. One hundred years of aspirin. Lancet 1997;350:437-439.
2. Cattaneo M. P2Y12 receptor antagonists: A rapidly expanding group of antiplatelet agents. Eur Heart J 2006;27:1010-1012.
3. Harrison P, Frelinger 3rd AL, Furman MI, Michelson AD. Measuring antiplatelet drug effects in the laboratory. Thromb Res 2007;120:323-336.
4. Frere C, Cuisset T, Quilici J, Camoin L, Carvajal J, Morange PE, et al. ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome. Thromb Haemost 2007;98:838-843.
5. Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, Goldenberg I, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004;109:3171-3175.
6. Hochholzer W, Trenk D, Bestehorn HP, Fischer B, Valina CM, Ferenc M, et al. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol 2006;48:1742-1750.
7. Geisler T, Langer H, Wydymus M, Gohring K, Zurn C, Bigalke B, et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J 2006;27:2420-2425.
8. Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schomig A, et al. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 2009;53:849-856.
9. Sibbing D, Schulz S, Braun S, Morath T, Stegherr J, Mehilli J et al. Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. J Thromb Haemost 2010;8:250-256.
10. Johnson A, Dovlatova N, Heptinstall S. Multiple electrode aggregometry and P2Y(12) antagonists. Thromb Haemost 2008;99:1127-1129.
11. Mani H, Kirchmayr K, Klaffling C, Schindewolf M, Luxembourg B, Linnemann B, et al. Influence of blood collection techniques on platelet function. Platelets 2004;15:315-318.
12. Bolliger D, Seeberger MD, Tanaka KA, Dell-Kuster S, Gregor M, Zenklusen U, et al. Pre-analytical effects of pneumatic tube transport on impedance platelet aggregome-try. Platelets 2009;20:458-465.
13. Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation. Thromb Haemost 2009;101:333-339.
14. Cattaneo M, Lecchi A, Zighetti ML, Lussana F. Platelet aggregation studies: Autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. Haematologica 2007;92:694-697.
15. Linnemann B, Schwonberg J, Mani H, Prochnow S, Lindhoff-Last E. Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: An adjustment for platelet count is not necessary. J Thromb Haemost 2008;6:677-683.
16. Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schomig A, et al. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008;99:121-126.
17. Kalb ML, Potura L, Scharbert G, Kozek-Langenecker SA. The effect of ex vivo anticoagulants on whole blood platelet aggregation. Platelets 2009;20:7-11.
18. Panzer S, Eichelberger B, Koren D, Kaufmann K, Male C. Monitoring survival and function of transfused platelets in Bernard-Soulier syndrome by flow cytometry and a cone and plate(let) analyzer (Impact-R). Transfusion 2007;47:103-106.
19. Shenkman B, Matetzky S, Fefer P, Hod H, Einav Y, Lubetsky A, et al. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests. Thromb Res 2008;122:336-345.
20. Matetzky S, Fefer P, Shenkman B, Varon D, Savion N, Hod H. Effectiveness of reloading to overcome clopidogrel non-responsiveness in patients with acute myocardial infarction. Am J Cardiol 2008;102:524-529.
21. Siller-Matula JM, Panzer S, Jilma B. Reproducibility and standardised reporting of the vasodilator-stimulated phospho-protein phosphorylation assay. Platelets 2008;19:551-554.
22. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
23. Toth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: A new device to measure platelet aggregation in whole blood. Thromb Haemost 2006;96:781-788.
24. Paniccia R, Antonucci E, Gori AM, Marcucci R, Giglioli C, Antoniucci D, et al. Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients. J Thromb Haemost 2007;5:1839-1847.